SGShailesh B. Gaikwad

Shailesh B. Gaikwad

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shailesh B. Gaikwad has a total of 106 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Intracranial Venous Reflux in a Patient with Rheumatic Heart Disease on Computed Tomography Angiography

    by Manoj K. Nayak, Anuj Prabhakar, Biswamohan Mishra, Shailesh B. Gaikwad, Manjari Tripathi

  • Real world outcomes of reperfusion treatments in acute ischemic stroke (AIS): a prospective cohort study

    by Pinky Chhatterpal, Deepti Vibha, Rajesh Kumar Singh, Awadh Kishor Pandit, Animesh Das, Arunmozhimaran Elavarasi, Rohit Bhatia, Achal Kumar Srivastava, Manjari Tripathi, Leve Joseph, et al.

    Introduction Reperfusion Treatment(RT) options for Acute Ischemic Stroke(AIS) within 24 hours include: intravenous thrombolysis(IVT)(within 4.5 hours) and/or mechanical thrombectomy(MT). The utilization of benefits in ‘real world’ scenario, especially in Lower-Middle Income countries(LMICs) is not known. We aimed to determine the ‘real-world’ utilization and effectiveness of RT. Patients and methods In a single-center prospective cohort study, we collected data of all AIS patients coming within 24 hours. Patients receiving RT(IVT/MT/both) and those who were ineligible and received medical management (MM) were compared for the clinical, radiological characteristics and outcomes at 90-days assessed by modified Rankin Scale (mRS). The secondary outcomes were poor outcome at 90 days(mRS 3-6), Barthel Index(BI), Caregiver Strain Index(CSI), Stroke Specific Quality of Life(SSQoL) and mortality. Results In the study period (January 2022-September 2023), there were 302 patients. The mean age was 55.9(SD:15.7) years and majority were males (64.9%). Patients who underwent RT (42.7%(129/302)) had similar clinical characteristics, except for lesser time to presentation, better Glasgow Coma Scale(GCS), and better median ASPECTS. IVT was given to 33.4%(101/302) and MT in 14.6%(44/302). The mRS at 90-days was significantly better in the RT group (RT:1(0;3), MM:3(1;5);P <0.001). RT was an independent protective factor (OR: 0.3(0.2;0.4); p-value:<0.001) for worse outcome (mRS 3-6). Other factors associated with mRS 3-6 at 90-days in multivariate analysis were high NIHSS and low ASPECTS at presentation. Conclusions RT is feasible and effective in LMICs. Since the burden of stroke is increasing in LMICs and mean age of stroke is lower, post-stroke disability prevention by RT is an important intervention.

  • Open Access

    Mechanical thrombectomy for acute ischemic stroke in a low- and middle-income country: primary outcomes from the GRASSROOT Trial

    by Dileep R Yavagal, Shailesh B Gaikwad, Deepti Vibha, Sunil K Narayan, K Nagarajan, Subba Reddy Kesavarupu, Mukesh Kumar Sharma, Rashmi Sharaf, Sriharish Vankayalapati, Amol Mehta, et al.

    Background and aims: Access to mechanical thrombectomy for acute ischemic stroke secondary to large vessel occlusion (LVO) is severely restricted in resource-constrained environments, largely owing to the prohibitive cost of existing approved devices. Objective: The GRASSROOT Trial is the first prospective thrombectomy study in a low- and middle-income country (LMIC) setting assessing the safety and efficacy of the novel Supernova stent retriever—engineered for highest-level performance across diverse patient populations. Methods: A prospective, single-arm, multicenter trial conducted in India enrolled patients with AIS due to internal carotid artery terminus, M1/M2 middle cerebral artery, or basilar artery occlusions presenting within 24 hours of symptom onset. Primary safety endpoints were symptomatic intracranial hemorrhage (sICH) within 24 hours and all-cause mortality at 90 days. Primary efficacy endpoint was successful reperfusion (modified Thrombolysis in Cerebral Infarction (mTICI) score ≥2b), with a 90-day modified Rankin Scale (mRS) score of 0–2 serving as the secondary efficacy endpoint. Results: Thirty-two consecutive eligible patients (mean age 58±16 years; 31% female; median National Institutes of Health Stroke Scale (NIHSS) score 14 (IQR 9–18), Alberta Stroke Program Early CT Score 8 (IQR 7–10)) were enrolled. Successful reperfusion (mTICI≥2b) after 1–3 passes of the Supernova stent retriever (median=1 (1–3)) was achieved in 30 (93.8%) patients without need for adjunctive rescue therapy. At 90 days, mortality was 9.4%, sICH 3.1%, and functional independence (mRS score 0–2) 50%. The median NIHSS score improved from 14 at baseline to 7 at discharge and to 4 at 90 days. First pass recanalization was observed in 22 (68.8%) patients. No device-related complications or deficiencies were observed. Conclusions: The GRASSROOT Trial demonstrates excellent safety and efficacy of the Supernova stent retriever in large vessel occlusions. High rate of first pass reperfusion together with value-based pricing could facilitate a significant advancement in acute stroke thrombectomy access in India and other LMICs. Trial registration number: NCT06249776 .


  • Open Access

    Comparative Assessments of PET and ASL MR Perfusion in the Evaluation of Early Dementia

    by Savyasachi Jain, Shailesh B Gaikwad, Bheru Dan Charan, Anu Gupta, Madhvi Tripathy

    Background: Overtly morbid dementing diseases have a prodromal MCI (mild cognitive impairment) phase which is crucial to recognize. Clinical scores provide an easy bedside assessment tool for holistic cognitive evaluation but fail to provide lead time. While routine biomarkers of brain atrophy are late to appear, non-contrast MRI perfusion studies like ASL may serve as a valuable alternative to 18F-FDG-PET for the recognition and classification of the degree of neurodegeneration in individuals with MCI, especially when FDG-PET is not available. Our study adds confidence as we noted brain regions where PET-ASL concordance was most robust and devised concordance with ACE-3 scores.Material and methods: We conducted a prospective study from Jan 2021 to Jan 2024. Cases were selected based on the inclusion and exclusion criteria, which have objective cognitive impairment. Healthy controls were selected. MRI and PET scans were performed in all cases. Perfusion values of arterial spine labeling, PET, and clinical examination were recorded.Results: We included 33 patients and 15 healthy controls in the study. We compared ASL and PET for all selected individuals. Our study showed that ASL can detect a hypo-perfusion region with a 91% sensitivity, 85.98% specificity, 89.8% PPV, and 87.62% NPV, with a diagnostic accuracy of 88.9%.Conclusion: ASL was a dependable replacement for the gold-standard FDG-PET. ASL may serve as a valuable alternative to 18F-FDG-PET for classifying the degree of neurodegeneration in individuals with prodromal AD, especially when FDG-PET is unavailable.

  • High flow pial arteriovenous fistula with dural sinus malformation of the posterior circulation

    by Nikhila Reddy, Shailesh B. Gaikwad, Savyasachi Jain, Bheru Dan Charan, Shariq Ahmad Shah

    Posterior fossa congenital pial arteriovenous fistulas are rare vascular anomalies associated with high morbidity. These anomalies often present challenges to neurointerventionists due to their complex morphological features. We successfully treated two technically challenging, infratentorial large pial arteriovenous fistulas (AVFs) associated with complete flow steal in the basilar artery. The first case involved an 18-year-old male with a posterior fossa single-hole AVF characterized by dilated venous pouches and retrograde venous reflux. After an unsuccessful initial coiling attempt, this patient was treated using a double microcatheter coiling technique, supported by a large balloon for flow control. The second case involved a 9-month-old infant with a complex two-hole posterior fossa pial AVF and a large venous sac. This patient was treated with coil embolization of the fistula and with balloon protection of the vertebrobasilar junction. Both patients recovered without postoperative complications and showed significant improvement on follow-up. These cases provide valuable insights into the management and characteristics of pial arteriovenous fistulas.

  • Open Access

    Persistent Craniopharyngeal Canal (Type 3C) with Vertebrobasilar Dolichoectasia and Bilateral Sclerochoroidal Calcification

    by Bheru Dan Charan, Savyasachi Jain, Shailesh B. Gaikwad

    The persistent craniopharyngeal canal is a rare, well-corticated midline congenital bony defect through the sphenoid bone between the sellar floor and the nasopharyngeal roof. The prevalence of persistent craniopharyngeal canal is reported to be 0.42%. A 42-year-old male was evaluated for nasal discharge and progressive vision loss; and underwent computed tomography and magnetic resonance imaging, which revealed a large craniopharyngeal canal with ectopic pituitary, lipoma, encephalocele, deformed globe with sclerochoroidal calcification and vertebrobasilar dolichoectasia. The presence of orbital and optic tract malformation, craniofacial anomalies, and tumors can be associated with the craniopharyngeal canal.

  • Open Access

    Endovascular Treatment of Mycotic Intracranial Aneurysms: A Series of Three Cases with Institutional Treatment Algorithm

    by Bheru Dan Charan, Shailesh B. Gaikwad, Sushant Agarwal, Savyasachi Jain

    Mycotic intracranial aneurysms (MIAs) are rare but can cause significant morbidity and mortality due to rupture. Most patients have additional systemic medical comorbidities making endovascular treatment a vital modality in the treatment of these aneurysms. We aimed to share our institutional experience with the role of endovascular therapy in the treatment of mycotic aneurysms with a literature review. We conducted a retrospective review of our patient database to identify individuals diagnosed with MIAs who underwent endovascular intervention at our institution between January 2002 and December 2021. We have found three patients with ruptured MIAs. All three patients had a heart disease with infective endocarditis. Two patients presented with subarachnoid hemorrhage (SAH) in which, one had a rebleed resulting in intracerebral hemorrhage (ICH), the third patient initially presented with ICH. Distal anterior cerebral artery (ACA) was the site of MIA in two cases and distal middle cerebral artery (MCA) in one patient. Two patients were treated with simple coiling and one patient was treated by glue (n-butyl cyanoacrylate [NBCAs]) injection within the aneurysm. There was no periprocedural complication with complete obliteration of the aneurysm and preservation of the parent artery. All the patients had good outcomes on follow-up. Two patients had a modified Rankin scale (mRS) score of 0 at 6 months and one patient had an mRS score of 3 at the end of 3 months whose preprocedure mRS score was 5. Endovascular embolization of MIAs with coils or liquid embolic agents can be performed in critically ill patients and is an excellent treatment modality with high occlusion rates and low procedural complications.


  • Open Access

    Mechanical Thrombectomy in Medium Vessels Occlusion (MeVOs): An Institutional Experience with M2 Divisions of Middle Cerebral Artery

    by Bheru Dan Charan, Shailesh B Gaikwad, Savyasachi Jain, Ajay Garg, Leve Joseph Devarajan Sebastian, M V Padma Srivastava, Rohit Bhatia, Awadh Kishore Pandit, Shashank Sarad Kale

    Background: Mechanical thrombectomy has been established as a safe, standard and effective treatment option for occlusions of the proximal segment of the middle cerebral artery (MCA), as demonstrated in numerous studies. However, performing thrombectomy in the M2 divisions of MCA presents inherent challenges. In this institutional experience, we aim to delineate the recanalisation rates achieved through mechanical thrombectomy in cases involving the M2 segment of the MCA.Methods: We conducted a retrospective analysis of patients who underwent thrombectomy due to M2 MCA occlusions in the period from January 2018 to December 2021. Various factors affecting recanalisation rates were assessed.Results: A total of 15 patients with M2 segment occlusions of the middle cerebral artery were included in the study, comprising 11 in the superior division and 4 in the inferior division. The successful recanalisation rate was 72.33%, with notably higher success observed in cases of inferior division occlusion. The primary outcome of our study was the mTICI recanalisation status, categorised as successful recanalisation (mTICI = 2b or mTICI = 3) and unsuccessful recanalisation (mTICI = 1 or mTICI = 2a) and mRS at 6 months. None of the predictors assessed reached statistical significance.Conclusions: Mechanical thrombectomy demonstrates favourable efficacy and recanalisation rates in cases of M2 MCA division occlusion. Notably, inferior division occlusions exhibit a higher likelihood of successful recanalisation.


  • Open Access

    An Institutional Perspective on the Number of Stent Retriever Pass and Rate of Recanalization in Mechanical Thrombectomy for Acute Ischemic Stroke: When to Stop?

    by Bheru Dan Charan, Shailesh B Gaikwad, Savyasachi Jain, Ajay Garg, Leve Joseph Devarajan Sebastian, Mv Padma Srivastava, Rohit Bhatia, Awadh Kishore Pandit, Shashank Sarad Kale

    Background and purpose: Mechanical thrombectomy is the standard treatment modality for flow restoration in acute ischemic stroke. In cases of persistent occlusion, the optimal number of retrieval attempts before considering procedure termination is currently undetermined and is a topic for research. Therefore in this study, we studied the impact of the number of stent retrieval maneuvers on the recanalization of vessels.Methods: In this retrospective single-center observational study we included 52 patients with large vessel occlusion who underwent stent retriever mechanical thrombectomy. Successful recanalization rate was defined as modified TICI (Thrombolysis in Cerebral Infarction) 2b or 3.Result: The overall successful recanalization rate was 44.24%. The recanalization rate per stent retrieval attempt was the highest in 1st attempt (28.84%) and no recanalization was observed with the 3rd, 5th, and 6th attempts (p<0.001). At most 6 retrieval attempts were used.Conclusions: After two retrieval attempts, 91% of the patients were successfully recanalized and other after the 5th attempt could not result in recanalization.


  • Open Access

    Emerging insights into cephalic neural crest disorders: A single center experience

    by Manoj Kumar Nayak, Biswamohan Mishra, Sebastian Levejoseph, Ajay Garg, Kalyan Sarma, Biswajit Sahoo, Manjari Tripathi, Shailesh B. Gaikwad

    Objectives: Neural crest cells (NCCs) are transient structures in the fetal life in vertebrates, which develop at the junctional site of the non-neural and neural ectoderm, sharing a common developmental origin for diverse diseases. After Epithelio-mesenchymal (EMT) of the NCCs within the neural tube, delamination of NCCs occurs. After delamination, the transformation of these cells into various cell lineages produces melanocytes, bones, and cartilage of the skull, cells of the enteric and peripheral nervous system. After the conversion, these cells migrate into various locations of the entire body according to the cell lineage. Abnormalities in neural crest (NC) formation and migration result in various malformations and tumors, known as neurocristopathy. Material and Methods: Herein, this case series describes a single-center experience in cephalic NC disorders over the past 3 years, including 17 cases of varying composition (i.e., vascular, dysgenetic, mixed, and neoplastic forms) involving the brain and occasionally skin, eyes, and face of the patients. Results: In our study of 17 patients with cephalic NC disease, 6 (35.3%) patients had vascular form, 5 (29.4%) had dysgenetic form, 4 (23.5%) had mixed form, and 2 (11.7%) had neoplastic form. Brain involvement in the form of vascular or parenchyma or both vascular and parenchymal was seen in all of our patients (100%), skin in 6 (35.3%) patients, eye in 2 (11.7%), and face in 1 (5.9%) patient. Treatment was planned according to the various manifestations of the disease. Conclusion: Neural crest diseases (NCDs) are a rare and under-recognized group of disorders in the literature and may have been under-reported due to a lack of awareness regarding the same. More such reporting may increase the repertoire of these rare disorders such that clinicians can have a high degree of suspicion leading to early detection and timely counseling and also improve preventive strategies and help in developing new drugs for these disorders or prevent them.